111 (YI) Return on Invested Capital (2024 - 2025)
111 (YI) reported Return on Invested Capital of 0.0% for Q4 2025, little changed on a YoY basis from 0.0% in Q4 2024, and up 76.26% sequentially from 0.0% in Q3 2025.
111 (YI) Return on Invested Capital (2024 - 2025) Analysis & Trends
111 (YI) has 2 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital rose to 0.0% in Q4 2025, from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2024 to a low of 0.01% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.87 Bn | 101.89 Bn | 4.04 Bn | 0.00% |
| 2 | Cencora | 60.86 Bn | 58.69 Bn | 3.59 Bn | 0.02% |
| 3 | Cardinal Health | 53.89 Bn | 49.95 Bn | 2.50 Bn | 0.00% |
| 4 | Henry Schein | 9.77 Bn | 9.63 Bn | 1.07 Bn | 0.00% |
| 5 | Akso Health | 3.06 Bn | 3.06 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 0.00% |
| 7 | Accendra Health | 247.64 Mn | -89.24 Mn | 278.03 Mn | 0.00% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -0.01% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |